283 related articles for article (PubMed ID: 28325997)
1. A comprehensive approach in high-grade glioma management: position statement from the Neuro-Oncology Scientific Club (NOSC), Shiraz, Iran.
Ansari M; Mosalaei A; Ahmadloo N; Rasekhi A; Geramizadeh B; Razmkon A; Anvari K; Afarid M; Dadras A; Nafarieh L; Mohammadianpanah M; Nasrolahi H; Hamedi SH; Omidvari S; Nami M
Ger Med Sci; 2017; 15():Doc05. PubMed ID: 28325997
[TBL] [Abstract][Full Text] [Related]
2. An overview of neuro-oncology research and practice in Iran, three years with the NOSC initiative.
Haddad P; Shazadi S; Samiei F; Kharrazi HH; Tabatabaeefar M; Rakhsha A; Faranoosh M; Torabi-Nami M; Dadras A; Liaghi A; Nafarieh L
Int J Clin Exp Med; 2015; 8(3):3946-55. PubMed ID: 26064296
[TBL] [Abstract][Full Text] [Related]
3. Contemporary management of low--grade glioma: a paradigm shift in neuro-oncology.
Hayhurst C
Pract Neurol; 2017 Jun; 17(3):183-190. PubMed ID: 28315827
[TBL] [Abstract][Full Text] [Related]
4. Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensus.
Schiff D; Van den Bent M; Vogelbaum MA; Wick W; Miller CR; Taphoorn M; Pope W; Brown PD; Platten M; Jalali R; Armstrong T; Wen PY
Neuro Oncol; 2019 Jul; 21(7):837-853. PubMed ID: 30753579
[TBL] [Abstract][Full Text] [Related]
5. Response assessment in neuro-oncology criteria: implementation challenges in multicenter neuro-oncology trials.
Pope WB; Hessel C
AJNR Am J Neuroradiol; 2011 May; 32(5):794-7. PubMed ID: 21474628
[No Abstract] [Full Text] [Related]
6. Italian consensus and recommendations on diagnosis and treatment of low-grade gliomas. An intersociety (SINch/AINO/SIN) document.
Rudà R; Angileri FF; Ius T; Silvani A; Sarubbo S; Solari A; Castellano A; Falini A; Pollo B; Del Basso De Caro M; Papagno C; Minniti G; De Paula U; Navarria P; Nicolato A; Salmaggi A; Pace A; Fabi A; Caffo M; Lombardi G; Carapella CM; Spena G; Iacoangeli M; Fontanella M; Germanò AF; Olivi A; Bello L; Esposito V; Skrap M; Soffietti R;
J Neurosurg Sci; 2020 Aug; 64(4):313-334. PubMed ID: 32347684
[TBL] [Abstract][Full Text] [Related]
7. Neuro-oncology: diagnosis and management of cerebral gliomas--past, present, and future.
Gutin PH; Posner JB
Neurosurgery; 2000 Jul; 47(1):1-8. PubMed ID: 10917341
[No Abstract] [Full Text] [Related]
8. Response assessment in neuro-oncology.
Quant EC; Wen PY
Curr Oncol Rep; 2011 Feb; 13(1):50-6. PubMed ID: 21086192
[TBL] [Abstract][Full Text] [Related]
9. Molecular neuro-oncology: a forward-looking perspective.
Wick W; O'Neill T
CNS Oncol; 2013 Nov; 2(6):491-3. PubMed ID: 25054819
[TBL] [Abstract][Full Text] [Related]
10. Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Erker C; Tamrazi B; Poussaint TY; Mueller S; Mata-Mbemba D; Franceschi E; Brandes AA; Rao A; Haworth KB; Wen PY; Goldman S; Vezina G; MacDonald TJ; Dunkel IJ; Morgan PS; Jaspan T; Prados MD; Warren KE
Lancet Oncol; 2020 Jun; 21(6):e317-e329. PubMed ID: 32502458
[TBL] [Abstract][Full Text] [Related]
11. The role of tumor board conferences in neuro-oncology: a nationwide provider survey.
Snyder J; Schultz L; Walbert T
J Neurooncol; 2017 May; 133(1):1-7. PubMed ID: 28421461
[TBL] [Abstract][Full Text] [Related]
12. [Magnetic resonance spectroscopy in gliomas].
Galanaud D; Chinot O; Metellus P; Cozzone P
Bull Cancer; 2005 Apr; 92(4):327-31. PubMed ID: 15888389
[TBL] [Abstract][Full Text] [Related]
13. The future of neuro-oncology.
Piepmeier JM
Acta Neurochir (Wien); 2009 Nov; 151(11):1343-8. PubMed ID: 19639245
[No Abstract] [Full Text] [Related]
14. Updates from the 2013 Society for Neuro-Oncology annual and World Federation for Neuro-Oncology quadrennial meeting.
Lukas RV; Amidei C
Tumori; 2014; 100(3):358-62. PubMed ID: 25076251
[TBL] [Abstract][Full Text] [Related]
15. Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Fangusaro J; Witt O; Hernáiz Driever P; Bag AK; de Blank P; Kadom N; Kilburn L; Lober RM; Robison NJ; Fisher MJ; Packer RJ; Young Poussaint T; Papusha L; Avula S; Brandes AA; Bouffet E; Bowers D; Artemov A; Chintagumpala M; Zurakowski D; van den Bent M; Bison B; Yeom KW; Taal W; Warren KE
Lancet Oncol; 2020 Jun; 21(6):e305-e316. PubMed ID: 32502457
[TBL] [Abstract][Full Text] [Related]
16. Is there a role for clinical practice guidelines in multidisciplinary tumor board meetings? A descriptive study of knowledge transfer between research and practice.
Kostaras X; Shea-Budgell MA; Malcolm E; Easaw JC; Roa W; Hagen NA
J Cancer Educ; 2012 Mar; 27(1):42-5. PubMed ID: 21882052
[TBL] [Abstract][Full Text] [Related]
17. Precision Neuro-oncology: the Role of Genomic Testing in the Management of Adult and Pediatric Gliomas.
Ramkissoon LA; Britt N; Guevara A; Whitt E; Severson E; Sathyan P; Gay L; Elvin J; Ross JS; Brown C; Stogner-Underwood K; Mott R; Kram D; Strowd R; Lesser GJ; Ramkissoon SH
Curr Treat Options Oncol; 2018 Jun; 19(8):41. PubMed ID: 29931654
[TBL] [Abstract][Full Text] [Related]
18. [The treatment of adult glioma is multiphasic].
Mäenpää HO
Duodecim; 2010; 126(14):1669-75. PubMed ID: 20804085
[TBL] [Abstract][Full Text] [Related]
19. Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD).
Wen PY; Cloughesy TF; Ellingson BM; Reardon DA; Fine HA; Abrey L; Ballman K; Bendszuz M; Buckner J; Chang SM; Prados MD; Pope WB; Gregory Sorensen A; van den Bent M; Yung WK
Neuro Oncol; 2014 Oct; 16 Suppl 7(Suppl 7):vii36-47. PubMed ID: 25313237
[TBL] [Abstract][Full Text] [Related]
20. Can artificial intelligence overtake human intelligence on the bumpy road towards glioma therapy?
Daisy PS; Anitha TS
Med Oncol; 2021 Apr; 38(5):53. PubMed ID: 33811540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
